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Abstract
Background Radiofrequency-generating energy devices
have been used clinically in musculoskeletal procedures to
provide hemostasis and capsular shrinkage (thermal cap-
sulorrhaphy). However, the dose-effects are not well
known.
Questions/Purposes We therefore determined dosage
effects of radiofrequency energy on bone, skin incisions,
and joint capsule in sheep.
Methods Five mature sheep had six 2.5-cm
2 tibial peri-
osteal defects and six 1.0-cm skin incisions assigned to six
treatments varying by watts and ﬂuence (f = watts  sec-
onds/cm
2): (1) untreated control, (2) 50 W for 9.5 seconds
(190f; n = 5), (3) 110 W for 4.3 seconds (190f; n = 5), (4)
170 W for 2.8 seconds (190f; n = 5), (5) 170 W for 5.6
seconds (380f; n = 5), or (6) 170 W for 8.4 seconds (570f;
n = 5). Outcomes included hemostasis, contraction, heal-
ing, and histomorphometry for inﬂammation and necrosis
at 2 weeks.
Results Radiofrequency energy application on skin at
190f or greater had more than 80% hemostasis and dose-
dependent contraction, inﬂammation, and necrosis.
Radiofrequency energy application on bone had good
(70%) hemostasis at 190f and complete ([95%) hemos-
tasis at 380f and 570f, without histologic or clinically
detectable necrosis.
Conclusions Hemostasis can be achieved with radiofre-
quency energy at 190f in skin and bone. Bone necrosis was
not detected at up to 570f. Using ﬂuence greater than 190f
in skin achieved dose-dependent necrosis and incisional
contraction.
Clinical Relevance Radiofrequency energy can be used
on bone and skin for hemostasis, but potential incisional
complications, such as necrosis and an atypical ﬁrm and
desiccated surface, should be expected.
Introduction
Radiofrequency-generating energy devices have been used
clinically in musculoskeletal procedures, such as chon-
droplasty [9, 13, 35, 39, 41], arthroscopic treatment of
intraarticular tissues [1, 3, 14, 21, 26, 29, 31, 33, 43],
meniscectomy [16, 25], and treatment of musculoskeletal
tumors [8, 12, 23, 24, 27, 34, 37], to provide hemostasis
and thermal capsulorrhaphy.
The potential clinical consequences from surgical blood
loss for patients undergoing these procedures include (1)
decreased intraoperative visualization, (2) increased risk of
blood transfusion, and (3) high incidence of postoperative
complications, such as development of postoperative
hematomas [19, 35], swelling and pain [19, 35], risk of
infection [19, 35, 38], and potentially delayed rehabilita-
tion, including second surgery [19, 35]. Surgeons and
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eases potentially transmitted on blood splash during total
arthroplasty [38], such as hepatitis B virus (HBV) and HIV.
In orthopaedics, from 3239 healthcare workers tested, 13%
had HBV infections develop [11]. After occupational
exposure to HIV-infected blood, the risk of infection after
percutaneous exposure has been estimated at approxi-
mately 0.3% and 0.09% after membrane mucous exposure
[11]. Physical barriers, such as visor masks, to block blood
exposure events fail to protect the surgeon from splash
[38]. Use of radiofrequency energy (RFE) would decrease
the risk of exposure to blood and thus reduce the peril of
acquired blood-borne diseases [18].
RFE is a form of electromagnetic energy that, when
applied to tissues with a high collagen content, causes the
heat-labile intramolecular cross-links to break and the
protein to undergo a transition from a highly organized
crystalline structure to a random, gel-like state [3]. The
level of energy, duration of treatment, and nature of the
tissues determine this thermal effect. The bipolar electrode
size and shape inﬂuences the extent of thermal modiﬁca-
tion of tissues, as does the pattern of operator use [3].
When temperature rises above 65C[ 2, 15, 17], collagen
denatures regardless of the source of thermal energy [3].
Electromagnetic energy can be applied between two points
on the tip of a probe (bipolar) or between one electrode tip
and a grounding plate (monopolar). In monopolar devices,
the molecular friction created in the tissues adjacent to the
probe produces heat. Thus, the actual source of heat is the
frictional resistance of the tissues rather than the probe.
With bipolar probes, the electromagnetic energy follows a
much shorter path through a conductive irrigating solution
or through the tissues between the tips of the probe. Less
current is required with a bipolar device than with a
monopolar device to achieve the same effect because the
current passes through a much smaller volume of tissue. In
addition, the depth of tissue damage relative to the probe
tip may be less with a bipolar device [3]. Saline-coupled
bipolar sealing technology uses bipolar RFE combined
with an automated, adjustable, but continuous, saline ﬂow
at the electrode tip to control the increase in tissue tem-
perature and thus control alterations to the tissue. Bipolar
RFE offers advantages for hemostasis by reducing the
tissue carbonization and necrosis that occurs with electro-
cautery. Speciﬁcally, use of a bipolar RFE device with
conductive ﬂuid avoids bone necrosis on CT and histology
when used on cortical and cancellous bone in vivo with
92% hemostasis and applied at a modest dose of 50 W for
11 seconds in an area of 2.9 cm
2 (190 ﬂuence [f = watts 
seconds/cm
2]) [6]. However, the dosage effects of RFE are
not well known.
We determined dosage effects of RFE on bone, skin
incisions, and joint capsule in sheep. We hypothesized: (1)
all dosages of RFE would produce hemostasis with mini-
mal necrosis in cortical bone and (2) increasing ﬂuence
greater than 190f, speciﬁcally 380f and 570f, would cause a
dose-dependent necrosis and contraction in soft tissue.
Materials and Methods
Five mature sheep had six 2.5-cm
2 circular periosteal
defects, three per tibia, made and assigned to treatment
using a commercially available bipolar RFE device clini-
cally introduced in 2005 and designed to accept a saline
(0.9% NaCl) drip. Treatment of the tibial periosteal defects
was as follows: (1) untreated control (n = 5), (2) 50 W for
9.5 seconds (190f; n = 5), (3) 110 W for 4.3 seconds
(190f; n = 5), (4) 170 W for 2.8 seconds (190f; n = 5), (5)
170 W for 5.6 seconds (380f; n = 5), or (6) 170 W for 8.4
seconds (570f; n = 5). Additionally, on the same sheep,
three 1.0-cm skin incisions were made with a scalpel in
tandem at the seventh intercostal space bilaterally (six
incisions/sheep) and the incisions were treated with RFE of
(1) 190f (n = 10), (2) 380f (n = 10), or (3) 570f (n = 10)
(Fig. 1). Treatments were assigned to the proximal, middle,
or distal incision sites such that each of the three RFE
dosages occurred at each site an equal number of times.
Power calculations were made based on assuming a 5%
alpha error level and a power greater than 0.8 for our
outcomes based on clinically meaningful effects. In
Marulanda et al. [30], bipolar sealer decreased total blood
loss by 40% and transfusions from 52% to 20% in patients
having hip arthroplasty. The power calculation was made
by using this effect size (a minimum of 40% bleeding
reduction), a SD of the hemostasis variables from our
previous work [6], and a 5% alpha error level (95% con-
ﬁdence level). Based on this power analysis, the n = 5
Fig. 1 An illustration of the surgical sheep model shows the
periosteal defects on the tibial cortical bone and intercostal skin
incisions to be treated with the bipolar RFE device.
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123sample size was estimated to be sufﬁcient to show at least a
40% reduction in blood loss with high power ([0.98).
Power-based SDs from published work of histomorphom-
etry on tibia cortical bone [5], using adult sheep of the
same size and age and the same dose of RFE on the same
site in the tibia, estimated a sample size of n = 5 would be
overpowered (power = 0.9–1.0) to observe differences
among our treatments for necrosis. Procedures performed
for this study were reviewed and approved by the Institu-
tional Animal Care and Use Committee at The Ohio State
University.
We used an Aquamantys
TM System generator and hand
piece (Salient Surgical Technologies, Inc, Portsmouth, NH)
to apply RFE to the defects, varying watts (50 W, 110 W,
or 170 W) or ﬂuence (190f, 380f, or 570f). The Aqua-
mantys
TM System is automated to vary the ﬂow rate (0.5–
36 mL/minute) depending on power setting (20–200 W) to
maintain the surface probe temperature at less than 100C
[16].
The sheep were induced with a combination of xylazine
hydrochloride (0.1 mg/kg dose; xylazine, 20 mg/mL) and
ketamine hydrochloride (2-mg/kg dose; Ketaset
1; Fort
Dodge Animal Health, Madison, NJ) and maintained under
general anesthesia with isoﬂuorane (1.5%; Isoﬂo
1; Abbott
Laboratories, North Chicago, IL). Under general anesthe-
sia, the sheep were placed in dorsal recumbency. Both
tibiae and intercostal spaces were clipped and aseptically
prepared. On the midmedial tibia, a 12-cm scalpel incision
was made, extending to the periosteum. A sterile, plastic
template was used to trace the defects (2.5 cm
2) and
standardize the distance between them (1.5 cm apart). A
Number 15 scalpel blade was used to cut the periosteum to
bone using the template. The template was removed. The
periosteum was stripped from the surface of the tibia cor-
tical bone 1 minute before application of the assigned RFE.
Subcutaneous tissue was closed using 2-0 polyglycolic
sutures in a simple continuous pattern. Staples were used
on skin. A bandage was applied on each tibia. The inter-
costal skin incisions (1 cm in length) were made using a
Number 10 scalpel blade full-thickness through the epi-
dermis and dermis. A template was used to determine size
and distance between incisions. Simple interrupted 2-0
nylon sutures were used in the skin after RFE application.
After surgery, the animals were allowed unrestricted
activity in a 4- by 8-foot cage; sheep were seen daily
postoperatively by one author (MM) to assess lameness,
drainage, and swelling. There were no intraoperative or
postoperative complications. Animals were euthanized by
overdose of barbiturate (100 mg/kg; Euthasol
TM; Virbac
Corp, Fort Worth, TX) at 2 weeks.
The outcome measurement for hemostasis in cortical
bone and skin incisions was the percentage of surface
without bleeding immediately and 1 minute after device
application. A 1-mm grid template was placed over the
bone and incision surface and the intersections were
counted as bleeding or not bleeding for the entire surface
and expressed as a percent. The outcome measure for skin
incision contraction was the percentage of reduction in
incision area 1 minute after device application. Estimates
were made by two blinded investigators (AB, MM). Skin
incisions also were quantiﬁed objectively in a blinded
fashion by two of us (MM, AB) daily for swelling (mea-
surement of swelling in centimeters from the incision at the
widest point) [5]. Final skin incision healing was assessed
blindly (AB, MM) as a score of 0 to 4 at 2 weeks (0 =
primary healing; 1 = minimal atypical surface; 2 = mild
atypical surface; 3 = moderate atypical surface; 4 =
marked atypical surface [4]).
Lameness was scored by one investigator (MM) as 0 to
5 for each hind limb (0 = no lameness, 1 = minimal,
2 = mild, 3 = moderate, 4 = marked, 5 = nonweight-
bearing [22]). At termination of the study at 2 weeks, the
cortical bone and skin incisions were harvested in cross
section from the center of the lesion for a measurement (in
millimeters) of visible depth of tissue change and cross-
sectional histologic analysis. Joint capsule contraction was
assessed ex vivo immediately after euthanasia by two
blinded investigators (MM, AB). Four 2-cm
2 joint capsule
specimens were harvested from the caudal femorotibial
joint capsule of all ﬁve sheep (n = 20) for 0, 190f, 380f, or
570f RFE application to the synovial surface. Objective
measurement of the width and length of the synovial sur-
face before and after device application was made by MM
and veriﬁed by AB in a blinded fashion.
After gross evaluation and measurements, we ﬁxed the
cross-sectioned blocks of the dorsomedial half of the tibial
cortical bone, skin incisions, and joint capsule in 10%
neutral-buffered formalin and sectioned en bloc. Tibia
specimens were decalciﬁed in 10% EDTA. Parafﬁn-
embedded sections (10 lm) were prepared and stained with
hematoxylin and eosin. Sections from each tibial sample
were evaluated by three investigators (SW, AB, MM) for
extracellular matrix staining, cellular morphology, and
distribution. We considered normal osteocytes to have dark
staining nuclei and lie within lacunae from which cana-
liculi radiate. Fine cytoplasmatic processes of osteocytes
occupied the canaliculi and communicated with adjacent
osteocytes [44].
Of multiple sections, all three investigators selected the
best and most representative from each tibial sample to be
analyzed by histomorphometry by one investigator (MM)
without knowledge of the groups. We used a point-count-
ing grid (250 lm) at 920 magniﬁcation to count the
number of total and empty lacunae at the periosteal zone
(grid on the dorsal surface of the tibia near the middle of
the periosteal defect) and endosteal zone (grid on the inner
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surement of the periosteal zone) and expressed as a
percentage of empty lacunae (number of empty lacunae/
number of total lacunae 9 100) (Fig. 2). Bone necrosis is
represented histologically as areas of completely empty
lacunae in bone [42]. Necrotic bone may be replaced
without any clinical implications or may sequester if
infection is present [42].
Skin incisions were scored blindly by two of us (AB,
SW) for amount of inﬂammatory cells and edema (0–4;
0 = none, 4 = marked) and necrosis (0–4; 0 = none,
4 = marked [32]). Inﬂammatory cells were monocyte/
macrophage cells. Proteinaceous ﬂuid, noted as diffuse
light pink or unstained nonﬁbrillar, acellular material in
between tissues planes was scored for presence and amount
of edema. Intracapsular femorotibial joint sections were
scored for presence of coagulation (dark pink amorphous
nonﬁbrillar appearance on polarized light within the
ﬁbrillar extracellular matrix [ECM]) as 0 to 4 (0 = ﬁbrillar
ECM; 1 = minimal amorphous nonﬁbrillar ECM;
2 = mild amorphous nonﬁbrillar ECM; 3 = moderate
amorphous nonﬁbrillar ECM; 4 = marked amorphous
nonﬁbrillar ECM [6]).
Descriptive variables included treatments, sheep, and
sides (eg, left versus right hind limbs or skin incisions),
whereas the treatments and sides were considered nested in
sheep. The intraobserver consistency when counting cells
under the microscope was assessed by counting the number
of total lacuna ﬁve times in the same deﬁned 250-lm
region of the same section. This represents approximately
200 lacunae per counting session. The coefﬁcient of
variation (CV) was calculated among the ﬁve measure-
ments in the same site to estimate the repeatability of
outcomes by one observer. The intraobserver CV value was
2.90% in the number of total lacunae outcome, conﬁrming
a low variation. Additionally, the total lacunae were
counted among three adjacent regions in the periosteal and
endosteal zones (total six regions) in the same section for
10 of control and 10 of 170 W for 8.4 seconds (570f)
groups to determine a variability of outcomes in the treated
sites of the bone specimens. The CV value was 5.29% in
the number of total lacunae outcome.
We used a repeated-measures ANOVA to perform
multiple comparisons between the treatment groups with
PROC MIXED statistical models for continuous outcomes
(ie, percent hemostasis, percent contraction, skin incision
wound swelling, and percent empty lacunae) and GEN-
MOD statistical models for categorical outcomes (ie,
scored data such as histologic coagulation and inﬂamma-
tion). Multiple comparisons were made among the three
treatments (170 W for 2.8 seconds [190f], 170 W for 5.6
seconds [380f], and 170 W for 8.4 seconds [570f]) for
percent contraction, skin incision swelling, and skin inci-
sion histologic scores. For skin incision swelling, the
comparisons were made in each time (eg, 5–15 postoper-
ative days). In bone, multiple comparisons were made
among the ﬁve treatments (50 W for 9.5 seconds [190f],
110 W for 4.3 seconds [190f], 170 W for 2.8 seconds
[190f], 170 W for 5.6 seconds [380f], and 170 W for 8.4
seconds [570f]) for percent hemostasis or the six treatments
(control, 50 W for 9.5 seconds [190f], 110 W for 4.3 sec-
onds [190f], 170 W for 2.8 seconds [190f], 170 W for 5.6
seconds [380f], and 170 W for 8.4 seconds [570f]) for the
number of empty lacunae. A commercial software program
(SAS
1 Version 8.2; SAS Institute Inc, Cary, NC) was used
for data analysis.
Results
RFE application on bone produced increased hemostasis
with greater ﬂuence (380f and 570f), without histologic or
clinically detectable necrosis. Speciﬁcally, tibial cortical
bone hemostasis was greater (p\0.01) at 380f
(96% ± 2.1%) and 570f (99% ± 0.7%) than at 190f
(70% ± 5.1%) (Table 1; Fig. 3). All tibial incisions healed
primarily without drainage or swelling. Histologically, on
the periosteal and endosteal zones, there was no increase in
empty lacunae among treatments. The empty lacunae were
distributed evenly in the bone, and no patches of empty
lacunae were seen. Many cells (mean 112 cells/250-lm
grid at x20 magniﬁcation ± 5) were morphologically
normal and housed in lacunae in all groups (Fig. 2). Con-
trary to expectation, on the endosteal zone, in the 50 W,
Fig. 2 A representative histologic section of the periosteal zone in
tibial cortical bone treated with 570f RFE, showing the microscope
grid (250 lm) and the ﬁeld counted, shows the evenly distributed
lacunae containing morphologically normal osteocytes (Stain, hema-
toxylin & eosin; original magniﬁcation, 920 magniﬁcation).
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empty lacunae than in the untreated control group. In all
tibiae, the periosteal zone had more (p\0.03) empty
lacunae than the endosteal zone, regardless of energy
application (Fig. 4).
RFE application on skin at 190f or greater produced
more than 84% hemostasis and a dose-dependent necrosis
of skin and subcutaneous tissues. Speciﬁcally, in the skin
incisions, hemostasis was 84% or greater for all ﬂuences
(190–570f). Skin incision contraction and joint capsule
contraction increased (p\0.03) with increased ﬂuence
(Fig. 5). There was no drainage from the skin incisions
after 72 hours. The 570f had a sustained and greater
(p\0.04) skin incisional swelling for the 2 weeks of the
study. None of the incisions were painful on palpation.
Eight of 10 190f skin incisions healed by primary apposi-
tion of skin edges. Variably, but more frequently
(p\0.01) than 190f, the 380f and 570f incisions devel-
oped a ﬁrm, dry, ﬂeeceless surface, scored as atypical
healing. After skin and subcutaneous tissue harvest, a dose-
dependent increase (p\0.02) in depth of visibly abnormal
tissue was measured (Fig. 6). On histologic evaluation, an
Table 1. Clinical and histologic variables
Site Outcome Control 50 W 9.5
seconds 190f
110 W 4.3
seconds 190f
170 W 2.8
seconds 190f
170 W 5.6
seconds 380f
170 W 8.4
seconds 570f
Tibia Hemostasis (%) 0 59 ± 12* 65 ± 10* 70 ± 5* 96 ± 2*
, 99 ± 1*
,
Skin incision Hemostasis (%) NA NA NA 84 ± 49 2 ± 39 7 ± 2

Healing score NA NA NA 4 (3.5–4) 2.5 (0.5–4)
 2 (0–4)

Joint capsule Coagulation score 0 (0) NA NA 1 (1–2)* 4 (0–4)* 0 (0–4)
Values are expressed as mean ± standard error of the mean or mean, with range in parentheses; *different from control (p\0.03);
different
from all three 190f treatments (50 W 9.5 seconds, 110 W 4.3 seconds, 170 W 2.8 seconds) (p\0.04);
different from 170 W 2.8 seconds 190f
treatment (p\0.02); NA = not applicable.
Fig. 3 A graph shows the percentage of hemostasis of cortical bone.
Tibial cortical bone hemostasis was greater (p\0.01) at 380f and
570f than at 190f.
Fig. 4 A graph shows the percentage of empty lacunae on the
periosteal and endosteal zones in the tibial cortical bone. On the
endosteal zone, in the 50 W, 190f RFE treatment group, there were
fewer (p\0.02) empty lacunae than in the untreated control group.
In all tibiae, the periosteal zone had more (p\0.03) empty lacunae
than the endosteal zone, regardless of energy application.
Fig. 5 A graph shows the percentage of contraction of skin incisions
(in vivo) and the percentage of contraction of the femorotibial joint
capsule (ex vivo) after RFE device application. Skin incision
contraction and joint capsule contraction increased (p\0.03) with
increased ﬂuence.
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observed with increased ﬂuence in the skin incisions
(Fig. 7). Sheep were clinically normal in health and gait
throughout the study, except one sheep, which had inter-
mittent, 2 hours’ duration lameness after recovery from
anesthesia in the hind limb treated with the higher ﬂuence
levels.
Discussion
RFE devices are used clinically in musculoskeletal proce-
dures to make incisions, control hemorrhage in bone, and
reduce joint laxity by inducing contraction of the joint
capsule and surrounding joint soft tissues (thermal capsu-
lorrhaphy). We aimed to determine if a range of dosages of
RFE would produce hemostasis with minimal necrosis in
cortical bone and if increasing ﬂuence greater than 190f,
speciﬁcally 380f and 570f, would cause a dose-dependent
necrosis and contraction in soft tissue.
Our study has several limitations. First, the power
analysis for our sample size was based on statistical cal-
culations for many of the parameters, such as
histomorphometry for osteonecrosis. Experimental studies
rely on histomorphometry as a highly rigorous and sensi-
tive assessment of bone necrosis, but the clinical
correlations to bone pain, drainage, or failed surgeries are
not published. In an animal study of subchondral bone in
naturally occurring osteoarthritis, correlative sections of
bone histomorphometry and clinical CT showed excellent
correlation for bone density, bone sclerosis, and bone
resorption [45]. In a previous publication in sheep using
RFE on bone, the CT correlated to histology [5]. Second,
we do not have a control using another device. In previous
work using similar RFE on sheep bone, electrocautery
induced char and less hemostasis [5]. In patients under-
going joint arthroplasty, RFE on bone reportedly produces
less blood loss, smoke, and tissue damage than electro-
cautery, including less decrease in hemoglobin
postoperatively [30]. Our focus was to compare dosages of
RFE for clinical use. Previous work provides sufﬁcient
evidence that RFE is superior to electrocautery for
hemostasis [5, 30]. Third, numerous key outcome variables
were semiquantitative and may have some inherent bias.
Assigned scores were used for outcome variables believed
to be important but difﬁcult to quantify, such as bleeding
intensity, swelling, and limb pain. Assignment of scores at
surgery was performed by multiple individuals and the
Fig. 6A–H Necrosis depth (mm; mean ± standard error of the mean
[SEM]) is shown at (A)1 0± 1 m, 170 W for 2.8 seconds, 190f (B)
12 ± 1 m, 170 W for 5.6 seconds, 380f, (C)1 6± 2 m, 170 W ﬁr 8.4
seconds, 570 w, and in the (D) untreated control (Stain, hematoxylin
& eosin). In the gross cross sections from the skin incisions at
2 weeks of healing, necrosis depth is shown at (E)3± 1 mm, 170 W
for 2.8 seconds, 190f; (F)4± 1 mm, 170 W for 5.6 seconds, 380f;
(G)9± 1 mm, 170 W for 8.4 seconds, 570f; and in the (H) untreated
control. A dose-dependent increase (p\0.02) in depth of visibly
abnormal tissue can be seen.
Fig. 7 A graph shows the histomorphology scores of the intercostal
space skin incisions for inﬂammation, edema, and necrosis. An
increase (p\0.04) in inﬂammation and necrosis can be seen with
increased ﬂuence.
1162 Menendez et al. Clinical Orthopaedics and Related Research
1
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application would be apparent to the surgeon and provide
some insight regarding the treatment. However, multiple
investigators were used in the scoring, one without any
knowledge of application.
All dosages (190f, 380f, and 570f) of RFE induced
hemostasis with minimal necrosis in cortical bone. Our
data on bone hemostasis correspond to clinical data pre-
sented by Marulanda et al. [30] that showed a substantial
reduction in the total blood loss and postoperative drainage
in primary hip arthroplasties. Our data on bone necrosis
correspond to clinical data by Bonutti et al. [7]. In 2386
patients who underwent knee arthroplasties, osteonecrosis
occurred in 24 patients or 1% [7]. Of the 24 patients, 10
had a history of arthroscopic de ´bridement with RFE. They
reported osteonecrosis on postarthroscopic MRI, whereas
preoperative MRI was normal. Cetik et al. [13], in a study
of 50 patients who underwent arthroscopic chondroplasties
and bipolar RFE, detected subchondral osteonecrosis in
two (4%) on the postoperative MRI performed 6 months
after the arthroscopy. Our data supported these clinical
ﬁndings and showed lack of necrosis at as much as 570f of
RFE on cortical bone. This low incidence of necrosis of
RFE on bone may be related to the high mineral content
(hydroxyapatite) and lower collagen content in cortical
bone compared with soft tissue and skin [30].
Increasing ﬂuence greater than 190f, speciﬁcally to 380f
and 570f, caused a dose-dependent necrosis and contrac-
tion in soft tissue, speciﬁcally for the skin and joint
capsule. Hecht et al. [20] reported increased stiffness of
RFE-treated joint capsular tissue returned to a normal value
by 6 weeks. However, Lopez and Markel [28] reported
canine ACLs treated with monopolar RFE were torn
approximately 55 days after treatment. In addition,
Schefﬂer et al. [36] reported the effect of RFE shrinkage on
the structural properties of the elongated ACL in a sheep
model. They reported the initial reduction of knee laxity
after RFE treatment could not be maintained at 24 weeks.
The literature supports RFE shrinkage of soft tissue, but
persistence and necrosis were not fully evaluated. Our
study showed dose-dependent necrosis was associated with
the contracture of soft tissue, at least skin and joint capsule.
This could result in an undesirable joint capsule contracture
and thus reduce joint mobility and delay rehabilitation.
Additional and longer-term investigation of the biologic
response to thermal modiﬁcation after cumulative dosages
of RFE using in vivo models is needed. The factors that
lead to capsular tissue failure, cellular death, and sub-
chondral osteonecrosis after thermal alteration, and the
threshold at which tissue becomes irreparable by biologic
processes, need to be deﬁned. RFE, in combination with
complementary blood management strategies such as pre-
operative autologous blood donation [10, 40], allogenic
blood transfusion [10, 40], hypotensive anesthesia [10, 40],
acute normovolemic hemodilution [10, 40], and recombi-
nant human erythropoietin [10, 40], may help to mitigate
surgical and postoperative bleeding. Reducing the need for
transfusion and delayed rehabilitation will decrease mor-
bidity and medical and ﬁnancial costs.
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